Northside Hospital,228 Riverstone Dr.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials
• Triple-negative breast cancer2 trials

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Gilead Sciences2 trials

Running trials

• Active, not recruiting

  Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  NCT05382286· Phase 3· Gilead Sciences· Source

• Active, not recruiting

  Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  NCT05382299· Phase 3· Gilead Sciences· Source